2018-04-18
Antithyroid drugs and congenital malformations
Publication
Publication
Nature Reviews Endocrinology p. 1- 2
A new study showed that propylthiouracil and methimazole use during pregnancy was associated with increased risk of congenital malformations. Intriguingly, the authors identified dose-dependent effects for methimazole but not propylthiouracil, whereas the recommended switch from methimazole to propylthiouracil during early pregnancy did not reduce the risk of congenital malformations.
Additional Metadata | |
---|---|
doi.org/10.1038/s41574-018-0012-6, hdl.handle.net/1765/105933 | |
Nature Reviews Endocrinology | |
Organisation | Department of Internal Medicine |
Korevaar, T., & Peeters, R. (2018). Antithyroid drugs and congenital malformations. Nature Reviews Endocrinology, 1–2. doi:10.1038/s41574-018-0012-6 |